Vial labeled 'BPC-157' with NX Peptide Therapeutics branding on a white background

BPC-157 Peptide vial with a label on a white background

REF BPC157-V5

BPC-157

BPC‑157 (Arginine) 10 mg — COA-verified ≥99 % purity (HPLC-verified), research-grade peptide

BPC-157 Arginine (Body Protection Compound 157) is a synthetic peptide derived from gastric juice protein BPC. Each batch is independently COA-verified by BT Labs (≥99 % HPLC purity) and supplied as a lyophilized 10 mg vial for research use.

Identity confirmed (independent COA)
Lyophilized; sterile vial
Same‑day dispatch from Dubai

Size 5 mg

5 mg 10 mg 15 mg

175.00 AED

≈ 35.00 / mg

PURITY HPLC tested RUO

Research use only.

Verified batch with independent COA included — assay ≥99 % purity.
Same‑Day Dubai; Express Worldwide
Easy returns on unopened vials within 7 days
Handled under cold chain where applicable and packed for transit stability.
Ships in 24h with temperature-controlled logistics Independent COA available for every batch Secure checkout

Formula: C62H98N16O22

M.W.: 1419.556 g/mol

Verified View Verified COA

Verification: Assay 99.0% · Lab: BT Labs

5 mg

175.00 AED

Tissue Healing

In rat models, gastric pentadecapeptide BPC 157 accelerated healing of transected Achilles tendons and improved tendon-to-bone integration. PubMed ↗
Faster tendon recovery

BPC-157 promoted tendon outgrowth, cell migration, and survival in injured Achilles tendons in a controlled rat model. [PubMed]
Soothes the gut lining

Repeated preclinical studies show BPC-157 protects the gastrointestinal mucosa and accelerates healing of ulcers and inflammatory bowel injury. [PubMed]
Heals strained joints

Improved healing of transected medial collateral ligaments with faster functional recovery versus controls in a rat injury model. [PubMed]
Speeds up healing

Activates VEGFR2-Akt-eNOS signaling and angiogenesis pathways implicated in vascular and wound recovery. [PubMed]
Calms inflammation

Reduces pro-inflammatory cytokines and oxidative-stress markers across multiple injury models. [PubMed]

Pentadecapeptide investigated in preclinical models for tissue repair, angiogenesis, and GI mucosal protection. For laboratory in‑vitro research use only; not for human or animal consumption.

Mechanism (preclinical)

Preclinical studies suggest fibroblast recruitment and migration, nitric-oxide/VEGFR2-associated angiogenesis, and modulation of inflammatory pathways.

Sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula

C62H98N16O22

Molecular Weight (g/mol)

—

PubChem

CID 108101

Wound Healing1

In animal and in‑vitro models, BPC‑157 has been associated with fibroblast proliferation and migration relevant to tissue repair.

Source

Angiogenesis & Ischemia2

Studies suggest pro‑angiogenic activity possibly involving VEGFR2‑mediated pathways and collateral vessel growth in ischemic models.

Source

Tendon & Ligament Models3

Preclinical data indicate enhanced tendon outgrowth and cell migration markers in injury models.

Source

Oxidative Stress Markers4

Reports describe reductions in certain oxidative stress markers in rodent GI contexts.

Source

Drug Side-Effect Models5

Rodent studies explore mitigation of selected drug-induced adverse effects (e.g., QTc changes, GI lesions).

Source

Honeybee Gut Study6

Field studies assessed GI outcomes in honeybees exposed to Nosema ceranae when feed was supplemented with BPC-157.

Source

For laboratory research use only (RUO).

Technical Data Sheet Download Data Sheet (PDF)

Certificate of Analysis

Verified (independent lab) Last verified: Sep 19, 2025

View COA

COA archive

COA (image)

COA – BPC-157 (Batch SID-005000035821078, Assay 2025-09-19, Lab BT Labs, v1.0.0)

HPLC

To protect yourself from unverified vendors and ensure you are getting pure, lab-tested material, review our comprehensive UAE Quality & Trust Guide before finalizing your purchase.

Because delicate amino acid chains can degrade quickly in extreme temperatures, our logistics team utilizes strict protocols for shipping peptides safely in UAE heat to guarantee product stability upon arrival.

Quality & Testing ≥99% purity HPLC verified

Lyophilized research peptide.

Verified

Form: Lyophilized peptide powder

Storage: Lyophilized: cool, dry, dark. Long‑term: frozen. Reconstituted: 2–8 °C

Reconstitution: Reconstitute with bacteriostatic water to desired concentration; swirl gently; do not vortex; document lot and date.

Research use only.

For laboratory research use only (RUO).

Frequently Asked Questions

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from a naturally occurring gastric protein. It is studied in preclinical research for its potential role in angiogenesis, cell migration, and soft-tissue recovery.

How is BPC-157 supplied?

Each vial contains 10 mg of lyophilized (freeze-dried) BPC-157 peptide powder with no fillers or excipients. It should be reconstituted with sterile bacteriostatic water before use.

What purity and verification does this batch have?

Every batch is independently COA-verified by BT Labs and tested ≥ 99 % purity by HPLC analysis. Certificates of Analysis are viewable directly on the product page for transparency and quality assurance.

How should BPC-157 be stored?

Keep lyophilized vials cool and away from light; long-term storage below 0 °C is recommended. Once reconstituted, store the solution between 2–8 °C and avoid multiple freeze-thaw cycles to preserve stability.

Where is this peptide manufactured and tested?

BPC-157 is sourced from industry-leading manufacturers and tested in accredited third-party analytical facilities (BT Labs) for identity and purity. Each lot’s COA is available on the product page for verification.